The molecular mechanisms of calpains action on skeletal muscle atrophy

Physiological Research

Volumn 65, Issue 4, 2016, Pages 547-560

  Huang, Jiaru ^a   Zhu, Xiaoping ^b  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Akt; Calpains; Cell signaling; Muscle wasting; UPP

Indexed keywords

ATP DEPENDENT 26S PROTEASE; CALPAIN; MUSCLE PROTEIN; PROTEASOME; PROTEIN KINASE B; UBIQUITIN;

ANIMAL; HUMAN; HYPERTROPHY; METABOLISM; MUSCLE ATROPHY; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

ANIMALS; CALPAIN; HUMANS; HYPERTROPHY; MUSCLE PROTEINS; MUSCULAR ATROPHY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 84997419107     PISSN: 08628408     EISSN: 18029973     Source Type: Journal    
DOI: 10.33549/physiolres.933087     Document Type: Review

References (126)

1. AGTEN A, MAES K, THOMAS D, CIELEN N, VAN HEES HW, DEKHUIJZEN RP, DECRAMER M, GAYANRAMIREZ G: Bortezomib partially protects the rat diaphragm from ventilator-induced diaphragm dysfunction. Crit Care Med 40: 2449-2455, 2012.
2. ARTHUR JS, ELCE JS, HEGADORN C, WILLIAMS K, GREER PA: Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol 20: 4474-4481, 2000.
3. BADALAMENTE MA, STRACHER A: Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23: 106-111, 2000.
4. BECKMANN JS, SPENCER M: Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance. Neuromuscul Disord 18: 913-921, 2008.
5. BILLGER M, WALLIN M, KARLSSON J-O: Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Difference in sensitivity of assembled and disassembled microtubules. Cell Calcium 9: 33-44, 1988.
6. BODINE SC, LATRES E, BAUMHUETER S, LAI VK, NUNEZ L, CLARKE BA, POUEYMIROU WT, PANARO FJ, NA E, DHARMARAJAN K, PAN ZQ, VALENZUELA DM, DECHIARA TM, STITT TN, YANCOPOULOS GD, GLASS DJ: Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001a.
7. BODINE SC, STITT TN, GONZALEZ M, KLINE WO, STOVER GL, BAUERLEIN R, ZLOTCHENKO E, SCRIMGEOUR A, LAWRENCE JC, GLASS DJ, YANCOPOULOS GD: Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014-1019, 2001b.
8. BRANCA D: Calpain-related diseases. Biochem Biophys Res Commun 322: 1098-1104, 2004.
9. CALNAN DR, BRUNET A: The FoxO code. Oncogene 27: 2276-2288, 2008.
10. CENTNER T, YANO J, KIMURA E, MCELHINNY AS, PELIN K, WITT CC, BANG ML, TROMBITAS K, GRANZIER H, GREGORIO CC, SORIMACHI H, LABEIT S: Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol 306: 717-726, 2001.
11. CHARTON K, SARPARANTA J, VIHOLA A, MILIC A, JONSON PH, SUEL L, LUQUE H, BOUMELA I, RICHARD I, UDD B: CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy. Hum Mol Genet 24: 3718-3731, 2015.
12. CHO K, CHO MH, SEO JH, PEAK J, KONG KH, YOON SY, KIM DH: Calpain-mediated cleavage of DARPP-32 in Alzheimer's disease. Aging Cell 14: 878-886, 2015.
13. CHOCKALINGAM PS, CHOLERA R, OAK SA, ZHENG Y, JARRETT HW, THOMASON DB: Dystrophinglycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy. Am J Physiol Cell Physiol 283: C500-C511, 2002.
14. CIECHANOVER A, ORIAN A, SCHWARTZ AL: Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 22: 442-451, 2000.
15. CLARKE BA, DRUJAN D, WILLIS MS, MURPHY LO, CORPINA RA, BUROVA E, RAKHILIN SV, STITT TN, PATTERSON C, LATRES E, GLASS DJ: The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 6: 376-385, 2007.
16. CLEMMONS DR: Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol Metab 20: 349-356, 2009.
17. COHEN S, BRAULT JJ, GYGI SP, GLASS DJ, VALENZUELA DM, GARTNER C, LATRES E, GOLDBERG AL: During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185: 1083-1095, 2009.
18. COVAULT J, LIU QY, EL-DEEB S: Calcium-activated proteolysis of intracellular domains in the cell adhesion molecules NCAM and N-cadherin. Brain Res 11: 11-16, 1991.
19. CROALL DE, CHACKO S, WANG Z: Cleavage of caldesmon and calponin by calpain: substrate recognition is not dependent on calmodulin binding domains. Biochim Biophys Acta 1298: 276-284, 1996.
20. DARGELOS E, BRULé C, STUELSATZ P, MOULY V, VESCHAMBRE P, COTTIN P, POUSSARD S: Up-regulation of calcium-dependent proteolysis in human myoblasts under acute oxidative stress. Exp Cell Res 316: 115-125, 2010.
21. DAVIES PJA, WALLACH D, WILLINGHAM MC, PASTAN I: Filamin-actin interaction. Dissociation of binding from gelation by Ca2+-activated proteolysis. J Biol Chem 253: 4036-4042, 1978.
22. DAYTON WR, GOLL DE, STROMER MH, RVILLE WJ, ZEECE MG, ROBSON RM: Some properties of a Ca2+-activated protease that may be involved in myofibrillar protein turnover. In: Proteases and Biological Control. Cold Spring Harbor Conferences on Cell Proliferation, Vol. 2. REICH E, RIFKIN DB, SHAW E (eds), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1975, pp 551-577.
23. 2+-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle. Biochemistry 15: 2150-2158, 1976a.
24. 2+-activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme. Biochemistry 15: 2159-2167, 1976b.
25. DU J, MITCH WE, WANG X, PRICE SR: Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-kappa B. J Biol Chem 275: 19661-19666, 2000.
26. ELCE JS, HEGADORN C, ARTHUR JS: Autolysis, Ca2+ requirement, and heterodimer stability in m-calpain. J Biol Chem 272: 11268-11275, 1997.
27. FANG CH, LI B, JAMES JH, YAHYA A, KADEER N, GUO X, XIAO C, SUPP DM, KAGAN RJ, HASSELGREN PO, SHERIFF S: GSK-3beta activity is increased in skeletal muscle after burn injury in rats. Am J Physiol Regul Integr Comp Physiol 293: R1545-R1551, 2007.
28. FAREED MU, EVENSON AR, WEI W, MENCONI M, POYLIN V, PETKOVA V, PIGNOL B, HASSELGREN PO: Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol 290: R1589-R1597, 2006.
29. FISCHER DR, SUN X, WILLIAMS AB, GANG G, PRITTS TA, JAMES JH, MOLLOY M, FISCHER JE, PAUL RJ, HASSELGREN PO: Dantrolene reduces serum TNFalpha and corticosterone levels and muscle calcium, calpain gene expression and protein breakdown in septic rats. Shock 15: 200-207, 2001.
30. FOLETTA VC, WHITE LJ, LARSEN AE, LéGER B, RUSSELL AP: The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch 461: 325-335, 2011.
31. FURLOW JD, WATSON ML, WADDELL DS, NEFF ES, BAEHR LM, ROSS AP, BODINE SC: Altered gene expression patterns in muscle ring finger 1 null mice during denervation-and dexamethasone-induced muscle atrophy. Physiol Genomics 45: 1168-1185, 2013.
32. GLASS DJ: Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37: 1974-1984, 2005.
33. GOLL DE, THOMPSON VF, TAYLOR RG, CHRISTIANSEN JA: Role of the calpain system in muscle growth. Biochimie 74: 225-237, 1992.
34. GOLL DE, THOMPSON VF, TAYLOR RG, OUALI A, CHOU RGR: The calpain system in muscle tissue. In: Calpain: Pharmacology and Toxicology of Calcium-Dependent Protease. WANG KKW, YUEN P-W (eds), Taylor & Francis, Philadelphia, 1999, pp 127-160.
35. GOLL DE, THOMPSON VF, LI H, WEI W, CONG J: The calpain system. Physiol Rev 83: 731-801, 2003.
36. GOMES MD, LECKER SH, JAGOE RT, NAVON A, GOLDBERG AL: Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98: 14440-14445, 2001.
37. GRUNE T, DAVIES KJ: The proteasomal system and HNE-modified proteins. Mol Aspects Med 24: 195-204, 2003.
38. GRUNE T, MERKER K, SANDIG G, DAVIES KJ: Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 305: 709-718, 2003.
39. HARADA F, KUNIMOTO M, YOSHIDA K-I: Distribution of ankyrin isoforms and their proteolysis after ischemia and reperfusion in rat brain. J Neurochem 69: 371-376, 1997.
40. HARWOOD AJ: Regulation of GSK-3: a cellular multiprocessor. Cell 105: 821-824, 2001.
41. HASSELGREN PO: Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism. Mol Biol Rep 26: 71-76, 1999.
42. HEMMINGS L, REES DJG, OHANIAN V, BOLTON SJ, GILMORE AP, PATEL B, PRIDDLE H, TREVITHICK JE, HYNES RO, CRITCHLEY DR: Talin contains three actin-binding sites each of which is adjacent to a vinculin-binding site. J Cell Sci 109: 2715-2726, 1996.
43. HERSHKO A, CIECHANOVER A: The ubiquitin system. Annu Rev Biochem 67: 425-479, 1998.
44. HO CY, STROMER MH, ROBSON RM: Identification of the 30 kDa polypeptide in post mortem muscle as a degradation product of troponin-T. Biochimie 76: 369-375, 1994.
45. HONG DH, FORSBERG NE: Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures. Mol Cell Endocrinol 108: 199-209, 1995.
46. HUANG J, FORSBERG NE: Role of calpain in skeletal-muscle protein degradation. Proc Natl Acad Sci U S A 95: 12100-12105, 1998.
47. JAGOE RT, LECKER SH, GOMES M, GOLDBERG AL: Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J 16: 1697-1712, 2002.
48. JUNGWIRTH U, GOJO J, TUDER T, WALKO G, HOLCMANN M, SCHöFL T, NOWIKOVSKY K, WILFINGER N, SCHOONHOVEN S, KOWOL CR, LEMMENS-GRUBER R, HEFFETER P, KEPPLER BK, BERGER W: Calpain-mediated integrin deregulation as a novel mode of action for the anticancer gallium compound KP46. Mol Cancer Ther 13: 2436-2449, 2014.
49. KANDARIAN SC, STEVENSON EJ: Molecular events in skeletal muscle during disuse atrophy. Exerc Sport Sci Rev 30: 111-116, 2002.
50. KOTLER DP: Cachexia. Ann Intern Med 133: 622-634, 2000.
51. KOURIE JI: Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol Cell Physiol 275: C1-C24, 1998.
52. KRAMEROVA I, KUDRYASHOVA E, TIDBALL JG, SPENCER MJ: Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum Mol Genet 13: 1373-1388, 2004.
53. KRAWIEC BJ, FROST RA, VARY TC, JEFFERSON LS, LANG CH: Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis. Am J Physiol Endocrinol Metab 289: E969-E980, 2005.
54. LECKER SH, SOLOMON V, MITCH WE, GOLDBERG AL: Muscle protein breakdown and the critical role of theubiquitin-proteasome pathway in normal and disease states. J Nutr 129: 227-237, 1999a.
55. LECKER SH, SOLOMON V, PRICE SR, KWON YT, MITCH WE, GOLDBERG AL: Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest 104: 1411-1420, 1999b.
56. LECKER SH, JAGOE RT, GILBERT A, GOMES M, BARACOS V, BAILEY J, PRICE SR, MITCH WE, GOLDBERG AL: Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51, 2004.
57. LéGER B, VERGANI L, SORARÙ G, HESPEL P, DERAVE W, GOBELET C, D'ASCENZIO C, ANGELINI C, RUSSELL AP: Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20: 583-585, 2006.
58. LIANG Z, BROWN RC, FLETCHER JC, OPSAHL-SORTEBERG HG: Calpain-mediated positional information directs cell wall orientation to sustain plant stem cell activity, growth and development. Plant Cell Physiol 56: 1855-1866, 2015.
59. LIN GD, CHATTOPADHYAY D, MAKI M, WANG KK, CARSON M, JIN L, YUEN PW, TAKANO E, HATANAKA M, DELUCAS LJ, NARAYANA SV: Crystal structure of calcium bound domain VI of calpain at 1.9 A resolution and its role in enzyme assembly, regulation, and inhibitor binding. Nat Struct Biol 4: 539-547, 1997.
60. LYNCH G: Memory and the brain: unexpected chemistries and a new pharmacology. Neurobiol Learn Mem 70: 82-100, 1998.
61. MAMMUCARI C, MILAN G, ROMANELLO V, MASIERO E, RUDOLF R, DEL PICCOLO P, BURDEN SJ, DI LISI R, SANDRI C, ZHAO J, GOLDBERG AL, SCHIAFFINO S, SANDRI M: FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6: 458-471, 2007.
62. MATSUMOTO A, FUJITA N, ARAKAWA T, FUJINO H, MIKI A: Influence of electrical stimulation on calpain and ubiquitin-proteasome systems in the denervated and unloaded rat tibialis anterior muscles. Acta Histochem 116: 936-942, 2014.
63. MAZÈRES G, LELOUP L, DAURY L, COTTIN P, BRUSTIS JJ: Myoblast attachment and spreading are regulated by different patterns by ubiquitous calpains. Cell Motil Cytoskeleton 63: 193-207, 2006.
64. MCCLUNG JM, JUDGE AR, TALBERT EE, POWERS SK: Calpain-1 is required for hydrogen peroxide-induced myotube atrophy. Am J Physiol Cell Physiol 296: C363-C371, 2009.
65. MCELHINNY AS, KAKINUMA K, SORIMACHI H, LABEIT S, GREGORIO CC: Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J Cell Biol 157: 125-136, 2002.
66. MUGURUMA M, NISHIMUTA S, TOMISAKA Y, ITO T, MATSUMURA S: Organization of the functional domains in membrane cytoskeletal protein talin. J Biochem 117: 1036-1042, 1995.
67. NADER GA, ESSER KA: Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J Appl Physiol 90: 1936-1942, 2001.
68. NELSON WB, SMUDER AJ, HUDSON MB, TALBERT EE, POWERS SK: Cross-talk between the calpain and caspase-3 proteolytic systems in the diaphragm during prolonged mechanical ventilation. Crit Care Med 40: 1857-1863, 2012.
69. NELSON WJ, TRAUB P: Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins. Mol Cell Biol 3: 1146-1156, 1983.
70. NOZAKI K, DAS A, RAY SK, BANIK NL: Calpeptin attenuated apoptosis and intracellular inflammatory changes in muscle cell. J Neurosci Res 89: 536-543, 2011.
71. ODA A, WAKAO H, FUJITA H: Calpain is a signal transducer and activator of transcription (STAT) 3 and STAT5 protease. Blood 99: 1850-1852, 2002.
72. O'SHEA JM, ROBSON RM, HUIATT TM, HARTZER MK, STROMER MH: Purified desmin from adult mammalian muscle: a peptide mapping comparison with desmins from adult mammalian and avian smooth muscle. Biochem Biophys Res Commun 89: 972-980, 1979.
73. PALLAFACCHINA G, CALABRIA E, SERRANO AL, KALHOVDE JM, SCHIAFFINO S: A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fibre type specification. Proc Natl Acad. Sci U S A 99: 9213-9218, 2002.
74. PARK S, NOZAKI K, GUYTON MK, SMITH JA, RAY SK, BANIK NL: Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats. J Neurosci Res 90: 2134-2145, 2012.
75. PEMRICK SM, GREBENAU RC: Qualitative analysis of skeletal myosin as a substrate of Ca2+-activated neutral protease: comparison of filamentous and soluble, native, and L2-deficient myosin. J Cell Biol 99: 2297-2308, 1984.
76. PIZON V, IAKOVENKO A, VAN DER VEN PFM, KELLY R, FATU C, FüRST DO, KARSENTI E, GAUTEL M: Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein. J Cell Sci 115: 4469-4482, 2002.
77. PLEUNI EH, ALBERTUS B, CHRISTIAN C: Diaphragm muscle fiber weakness and ubiquitin-proteasome activation in critically ill patients. Am J Respir Crit Care Med 191: 1126-1138, 2015.
78. PURINTRAPIBAN J, WANG MC, FORSBERG NE: Degradation of sarcomeric and cytoskeletal proteins in cultured skeletal muscle cells. Comp Biochem Physiol B Biochem Mol Biol 136: 393-401, 2003.
79. QIN QY, LIAO GH, MICHEL B, BI XN: Role of calpain-mediated p53 truncation in semaphorin 3A-induced axonal growth regulation. Proc Natl Acad Sci U S A 107: 13883-13887, 2010.
80. RENA G, GUO S, CICHY SC, UNTERMAN TG, COHEN P: Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179-17183, 1999.
81. ROBYN MM, ESTHER V, GRAHAM DL: Ca2+ activation of diffusible and bound pools of μ-calpain in rat skeletal muscle. J Physiol 576: 595-612, 2006.
82. SAKAMOTO K, HIRSHMAN MF, ASCHENBACH WG, GOODYEAR LJ: Contraction regulation of Akt in rat skeletal muscle. J Biol Chem 277: 11910-11917, 2002.
83. SAKAMOTO K, ASCHENBACH WG, HIRSHMAN MF, GOODYEAR LJ: Akt signaling in skeletal muscle: regulation by exercise and passive stretch. Am J Physiol Endocrinol Metab 285: 1081-1088, 2003.
84. SALAZAR JJ, MICHELE DE, BROOKS SV: Inhibition of calpain prevents muscle weakness and disruption of sarcomere structure during hindlimb suspension. J Appl Physiol 108: 120-127, 2010.
85. SANDOVAL IV, WEBER K: Calcium-induced inactivation of microtubule formation in brain extracts. Presence of a calcium-dependent protease acting on polymerization-stimulating microtubule associated proteins. Eur J Biochem 92: 463-470, 1978.
86. SANDRI M: Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 45: 2121-2129, 2013.
87. SANDRI M, SANDRI C, GILBERT A, SKURK C, CALABRIA E, PICARD A, WALSH K, SCHIAFFINO S, LECKER SH, GOLDBERG AL: Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004.
88. SARAH SJ, NEIL CO, MARGARET FC, TIM P, STEWART MG: The calpain system and cancer. Nat Rev Cancer 11: 364-374, 2011.
89. SATO N, FUJIO Y, YAMADA-HONDA F, FUNAI H, WADA A, KAWASHIMA S, AWATA N, SHIBATA N: Elevated calcium level induces calcium-dependent proteolysis of A-CAM (N-cadherin) in heart - analysis by detergent-treated model. Biochem Biophys Res Commun 217: 649-653, 1995.
90. SATO S, FUJITA N, TSURUO T: Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A 97: 10832-10837, 2000.
91. SCARAMUZZINO DA, MORROW JS: Calmodulin-binding domain of recombinant erythrocyte β-adducin. Proc Natl Acad Sci U S A 90: 3398-3402, 1993.
92. SCHWARTZ AL, CIECHANOVER A: Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49: 73-96, 2009.
93. SHIRAHA H, GLADING A, CHOU J, JIA Z, WELLS A: Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol 22: 2716-2727, 2002.
94. SIECK GC, MANTILLA CB: Effect of mechanical ventilation on the diaphragm. N Engl J Med 358: 1392-1394, 2008.
95. SIEMS W, CAPUOZZO E, LUCANO A, SALERNO C, CRIFÒ C: High sensitivity of plasma membrane ion transport ATPases from human neutrophils towards 4-hydroxy-2, 3-trans-nonenal. Life Sci 73: 2583-2590, 2003.
96. SMITH IJ, DODD SL: Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle. Exp Physiol 92: 561-573, 2007.
97. SMITH IJ, LECKER SH, HASSELGREN PO: Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 295: E762-E771, 2008.
98. SMUDER AJ, NELSON WB, HUDSON MB, KAVAZIS AN, POWERS SK: Inhibition of the ubiquitin-proteasome pathway does not protect against ventilator-induced accelerated proteolysis or atrophy in the diaphragm. Anesthesiology 121: 115-126, 2014.
99. SNEDDON AA, DELDAY MI, MALTIN CA: Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-alpha activity. Am J Physiol Endocrinol Metab 279: E188-E195, 2000.
100. SOLOMON V, GOLDBERG AL: Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 271: 26690-26697, 1996.
101. SOLOMON V, LECKER SH, GOLDBERG AL: The N-end rule pathway catalyzes a major fraction of the protein degradation in skeletal muscle. J Biol Chem 273: 25216-25222, 1998.
102. SPENCER MJ, MELLGREN RL: Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum Mol Genet 11: 2645-2655, 2002.
103. STABACH PR, CIANCI CD, GLANTZ SB, ZHANG Z, MORROW JS: Site-directed mutagenesis of aII spectrin at codon 1175 modulates its μ-calpain susceptibility. Biochemistry 36: 57-65, 1997.
104. STALKER TJ, SKVARKA CB, SCALIA R: A novel role for calpains in the endothelial dysfunction of hyperglycemia. FASEB J 17: 1511-1513, 2003.
105. STEVENSON EJ, GIRESI PG, KONCAREVIC A, KANDARIAN SC: Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 551: 33-48, 2003.
106. STITT TN, DRUJAN D, CLARKE BA, PANARO F, TIMOFEYVA Y, KLINE WO, GONZALEZ M, YANCOPOULOS GD: The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
107. SUGITA H, KANEKI M, SUGITA M, YASUKAWA T, YASUHARA S, MARTYN JA: Burn injury impairs insulinstimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab 288: E585-E591, 2005.
108. SUZUKI A, KIM K, IKEUCHI Y: Proteolytic cleavage of connectin/titin. Adv Biophys 33: 53-64, 1996.
109. TAKAHASHI A, KUREISHI Y, YANG J, LUO Z, GUO K, MUKHOPADHYAY D, IVASHCHENKO Y, BRANELLEC D, WALSH K: Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol Cell Biol 22: 4803-4814, 2002.
110. TAVEAU M, BOURG N, SILLON G, ROUDAUT C, BARTOLI M, RICHARD I: Calpain3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol 23: 9127-9135, 2003.
111. TAWA NE, ODESSEY R, GOLDBERG AL: Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest 100: 197-203, 1997.
112. TAYLOR RG, GEESINK GH, THOMPSON VF, KOOHMARAIE M, GOLL DE: Is Z-disk degradation responsible for postmortem tenderization? J Anim Sci 73: 1351-1367, 1995.
113. TERADA N, PATEL HR, TAKASE K, KOHNO K, NAIRN AC, GELFAND EW: Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci U S A 91: 11477-11481, 1994.
114. TIDBALL JG, SPENCER MJ: Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 545: 819-828, 2002.
115. TSUNEKAWA S, TAKAHASHI K, ABE M, HIWADA K, OZAWA K, MURACHI T: Calpain proteolysis of free and bound forms of calponin, a troponin T-like protein in smooth muscle. FEBS Lett 250: 493-496, 1989.
116. WANG KK, ROUFOGALIS BD, VILLALOBO A: Characterization of the fragmented forms of calcineurin produced by calpain I. Biochem Cell Biol 67: 703-711, 1989.
117. WANG L, LUO GJ, WANG JJ, HASSELGREN PO: Dexamethasone stimulates proteasome-and calcium-dependent proteolysis in cultured L6 myotubes. Shock 10: 298-306, 1998.
118. WEI W, YANG H, CAO P, MENCONI M, CHAMBERLAIN C, PETKOVA V, HASSELGREN PO: Degradation of C/EBPβ in cultured myotubes is calpain-dependent. J Cell Physiol 208: 386-398, 2006.
119. WELSH GI, MILLER CM, LOUGHLIN AJ, PRICE NT, PROUD CG: Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett 421: 125-130, 1998.
120. WILLIAMS AB, DECOURTEN-MYERS GM, FISCHER JE, LUO G, SUN X, HASSELGREN PO: Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J 13: 1435-1443, 1999.
121. WING SS: Control of ubiquitination in skeletal muscle wasting. Int J Biochem Cell Biol 37: 2075-2087, 2005.
122. WU M, FALASCA M, BLOUGH ER: Akt/protein kinase B in skeletal muscle physiology and pathology. J Cell Physiol 226: 29-36, 2010.
123. YOSHIDA K, INUI M, HARADA K, SAIDO TC, SORIMACHI H, ISHUIRA S, ISHIHARA T, KAWASHIMA S, SOBUE K: Reperfusion of rat heart after brief ischemia induces proteolysis of calspectrin (nonerythroid spectrin or fodrin) by calpain. Circ Res 77: 603-610, 1995.
124. YOSHIDA M, SUZUKI A, SHIMIZU T, OZAWA E: Proteinase-sensitive sites on isolated rabbit dystrophin. J Biochem 112: 433-439, 1992.
125. YOSHIKAWA Y, MUKAI H, HINO F, ASADA K, KATO I: Isolation of two novel genes, down-regulated in gastric cancer. Jpn J Cancer Res 91: 459-463, 2000.
126. ZHAO J, BRAULT JJ, SCHILD A, CAO P, SANDRI M, SCHIAFFINO S, LECKER SH, GOLDBERG AL: FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483, 2007.